-
DE
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) used to treat HIV-associated lipodystrophy in adults.
Tesamorelin is a synthetic analogue of growth hormone-releasing hormone (GHRH) used to treat HIV-associated lipodystrophy in adults.
Tesamorelin is a synthetically produced peptide hormone that closely resembles the naturally occurring human growth hormone-releasing hormone (GHRH). It consists of 44 amino acids and is administered as a subcutaneous injection. In clinical medicine, tesamorelin is marketed under the brand name Egrifta.
Tesamorelin is approved for the treatment of HIV-associated lipodystrophy in adults. This condition is a metabolic complication frequently observed in HIV-positive patients receiving antiretroviral therapy, characterized by unwanted accumulation of visceral adipose tissue (abdominal fat). Tesamorelin is specifically indicated to reduce this excess visceral fat.
Tesamorelin binds to GHRH receptors in the anterior pituitary gland, stimulating the release of growth hormone (GH). The released growth hormone promotes lipolysis, the breakdown of fat tissue, particularly in the abdominal region. Unlike direct administration of growth hormone, tesamorelin mimics the physiological mechanism of growth hormone secretion, supporting a more natural regulation of growth hormone levels.
The recommended dose is 2 mg of tesamorelin administered once daily as a subcutaneous injection into the abdominal area. Injections should ideally be given at the same time each day. Patients may self-administer the injection after appropriate training. Regular medical monitoring is required throughout treatment.
Like all medications, tesamorelin can cause side effects. Commonly reported side effects include:
Patients with diabetes or pre-diabetes should be closely monitored, as tesamorelin may influence insulin resistance.
Tesamorelin must not be used in patients with:
Tesamorelin may interact with several medications. Particular caution is advised with:
In clinical trials, tesamorelin demonstrated a significant reduction in visceral adipose tissue in HIV-infected patients with lipodystrophy. Treatment not only improved cosmetic aspects but also metabolic parameters such as triglyceride levels. However, the effect is sustained only with continued therapy; visceral fat may return after discontinuation of treatment.
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For Healthy Oral Flora & Dental Care
Formulated lozenges with Dentalac®, lactic acid bacteria, and Lactoferrin CLN®
For your universal protection
As one of the most valuable proteins in the body, lactoferrin is a natural component of the immune system.
For your iron balance
Specially formulated for your iron balance with plant-based curry leaf iron, Lactoferrin CLN®, and natural Vitamin C from rose hips.